Journal Article Epublish 14 citations
PubMed: 35492342 DOI: 10.3389/fmed.2022.868954
COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections.
Front Med (Lausanne) 9:868954
Authors: Nathalie Schwab, Ronny Nienhold, Maurice Henkel, Albert Baschong, Anne Graber, Angela Frank, Nadine Mensah, Jacqueline Koike, Claudia Hernach, Melanie Sachs, Till Daun, Veronika Zsikla, Niels Willi, Tobias Junt, Kirsten D Mertz
Affiliations
- Institute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
- Department of Radiology, University Hospital Basel, Basel, Switzerland.
- Novartis Institutes for BioMedical Research, Basel, Switzerland.
- University of Basel, Basel, Switzerland.
Abstract
Coronavirus disease 2019 (COVID-19) mortality can be estimated based on reliable mortality data. Variable testing procedures and heterogeneous disease course suggest that a substantial number of COVID-19 deaths is undetected. To address this question, we screened an unselected autopsy cohort for the presence of SARS-CoV-2 and a panel of common respiratory pathogens. Lung tissues from 62 consecutive autopsies, conducted during the first and second COVID-19 pandemic waves in Switzerland, were analyzed for bacterial, viral and fungal respiratory pathogens including SARS-CoV-2. SARS-CoV-2 was detected in 28 lungs of 62 deceased patients (45%), although only 18 patients (29%) were reported to have COVID-19 at the time of death. In 23 patients (37% of all), the clinical cause of death and/or autopsy findings together with the presence of SARS-CoV-2 suggested death due to COVID-19. Our autopsy results reveal a 16% higher SARS-CoV-2 infection rate and an 8% higher SARS-CoV-2 related mortality rate than reported by clinicians before death. The majority of SARS-CoV-2 infected patients (75%) did not suffer from respiratory co-infections, as long as they were treated with antibiotics. In the lungs of 5 patients (8% of all), SARS-CoV-2 was found, yet without typical clinical and/or autopsy findings. Our findings suggest that underreporting of COVID-19 contributes substantially to excess mortality. The small percentage of co-infections in SARS-CoV-2 positive patients who died with typical COVID-19 symptoms strongly suggests that the majority of SARS-CoV-2 infected patients died from and not with the virus.
MeSH
Infections, Mortality, Lung, Autopsy, Sars Virus, Coinfection, Covid-19, Sars-Cov-2
Cited by
- Microbial diversity and antimicrobial susceptibility in endotracheal tube biofilms recovered from mechanically ventilated COVID-19 patients. Biofilm, 2022
- Probability Samples Provide a Means of Benchmarking and Adjusting for Data Collected From Nonprobability Samples. Am J Public Health, 2023
- Unbiased screen for pathogens in human paraffin-embedded tissue samples by whole genome sequencing and metagenomics. Front Cell Infect Microbiol, 2022
- COVID-19 mortality attenuated during widespread Omicron transmission, Denmark, 2020 to 2022. Euro Surveill, 2023
- Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19-experiences of a longitudinal series of 92 patients. Virchows Arch, 2023
- A Systematic Review of Lung Autopsy Findings in Elderly Patients after SARS-CoV-2 Infection. J Clin Med, 2023
- Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan. J Pathol Transl Med, 2023
- [Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany]. Dtsch Med Wochenschr, 2024